Presentation at The Evidence and Organisations in Development Conference, at the University of Edinburgh’s Centre for Medical Anthropology and the Centre for African Studies.
Keynote address by Dr. Eric Goosby of UCSF, presented at CFAR HIV Research in International Settings (CHRIS) meeting in San Diego, October 1, 2014. Dr. Goosby discussed. "Global Health Delivery and Diplomacy: The Long Road to Sustainable Programs."
A qualitative assessment of the context and enabling environment for the cont...ILRI
Poster by Nicholas Ngwili, Nancy Johnson, Raphael Wahome, Samuel Githigia, Kristina Roesel and Lian Thomas presented at Tropentag 2021, 15-17 September 2021.
WHO Guidelines for Policymakers - World Hepatitis Day 2019Khubaib Samdani
WHO released guidelines for policymaker on World Hepatitis Day 2019. I am discussing two (1st and 10th) of those guidelines briefly in this presentation.
I presented this on webinar titled 'Session on Policy Reform' organized by Volunteer Force Against Hepatitis Transmission (VFAHT) on 22nd July, 2020.
You can watch the presentation here: https://www.facebook.com/vfaht.org/videos/889905641498191/
Top 10 messages for policymakers:
https://www.who.int/campaigns/world-hepatitis-day/2019/10-messages-for-policymakers
Keynote address by Dr. Eric Goosby of UCSF, presented at CFAR HIV Research in International Settings (CHRIS) meeting in San Diego, October 1, 2014. Dr. Goosby discussed. "Global Health Delivery and Diplomacy: The Long Road to Sustainable Programs."
A qualitative assessment of the context and enabling environment for the cont...ILRI
Poster by Nicholas Ngwili, Nancy Johnson, Raphael Wahome, Samuel Githigia, Kristina Roesel and Lian Thomas presented at Tropentag 2021, 15-17 September 2021.
WHO Guidelines for Policymakers - World Hepatitis Day 2019Khubaib Samdani
WHO released guidelines for policymaker on World Hepatitis Day 2019. I am discussing two (1st and 10th) of those guidelines briefly in this presentation.
I presented this on webinar titled 'Session on Policy Reform' organized by Volunteer Force Against Hepatitis Transmission (VFAHT) on 22nd July, 2020.
You can watch the presentation here: https://www.facebook.com/vfaht.org/videos/889905641498191/
Top 10 messages for policymakers:
https://www.who.int/campaigns/world-hepatitis-day/2019/10-messages-for-policymakers
Weak health systems are widely recognized, even by disease-specific initiatives, as a critical obstacle to improving health. There is a far greater appreciation than before of the role of policy and systems research, be it on health financing, social participation or political analysis, in informing efforts to strengthen health systems and thus improve health.
From Advocacy to Accountability: Empowering communities throughout the UHC Pr...HFG Project
This presentation was presented by Ricardo Valladares Cardona at a side session at the Prince Mahidol Award Conference (PMAC) in Bangkok, Thailand, on January 29, 2017.
Behavioral Health Navigator Presentation by Emerson Evans 12-12-13Office of HIV Planning
Emerson Evans (AACO) presented on a SAMHSA-funded behavioral health navigator program on 12-12-13. This program in Philadelphia was discussed with the Philadelphia EMA Ryan White Part A Planning Council.
COUNTDOWN on WHO 2020 Targets: A Focus on helminthiasisCOUNTDOWN on NTDs
Professor Russell Stothard, COUNTDOWN's programme Director attended the Swiss Tropical and Public Health Institute's Winter symposium titled 'Helminth Infection - from Transmission to Control'
COUNTDOWN on WHO 2020 Targets: Strengthening Health Systems Interventions for...COUNTDOWN on NTDs
This presentation was given by Professor Russell Stothard on 27th June 2019 during Nigeria's 1st International Scientific Conference on NTDs Control and Elimination in Nigeria
Weak health systems are widely recognized, even by disease-specific initiatives, as a critical obstacle to improving health. There is a far greater appreciation than before of the role of policy and systems research, be it on health financing, social participation or political analysis, in informing efforts to strengthen health systems and thus improve health.
From Advocacy to Accountability: Empowering communities throughout the UHC Pr...HFG Project
This presentation was presented by Ricardo Valladares Cardona at a side session at the Prince Mahidol Award Conference (PMAC) in Bangkok, Thailand, on January 29, 2017.
Behavioral Health Navigator Presentation by Emerson Evans 12-12-13Office of HIV Planning
Emerson Evans (AACO) presented on a SAMHSA-funded behavioral health navigator program on 12-12-13. This program in Philadelphia was discussed with the Philadelphia EMA Ryan White Part A Planning Council.
COUNTDOWN on WHO 2020 Targets: A Focus on helminthiasisCOUNTDOWN on NTDs
Professor Russell Stothard, COUNTDOWN's programme Director attended the Swiss Tropical and Public Health Institute's Winter symposium titled 'Helminth Infection - from Transmission to Control'
COUNTDOWN on WHO 2020 Targets: Strengthening Health Systems Interventions for...COUNTDOWN on NTDs
This presentation was given by Professor Russell Stothard on 27th June 2019 during Nigeria's 1st International Scientific Conference on NTDs Control and Elimination in Nigeria
Presentation given at the launch of COUNTDOWN in CameroonCOUNTDOWN on NTDs
Providing an overview of progress and Neglected Tropical Diseases in Cameroon and highlighting future COUNTDOWN activities, this presentation was given at the launch in Cameroon.
Co-ordinated malaria research for better policy and practice: the role of res...ACT Consortium
Prof. David Schellenberg from the London School of Hygiene & Tropical Medicine presents on behalf of the ACT Consortium at the European Congress on Tropical Medicine and International Health in Basel, Switzerland, 8 September 2015
Day 1: Challenges and opportunities for better detection, diagnosis and clini...KTN
The focus of this session is to explore how the UK health system is currently responding to the increasing number of patients with multiple long-term conditions and the impacts of healthcare inequalities on patient outcomes. We will also explore opportunities for businesses to bring about much needed innovations in the prevention, early diagnosis and management of multi-morbidity.
After the successful NSP 2017-2025,Goi is lauching NSP 2017-2025 for elimination of TB on 24th march( World TB day ) 2017. Module is on MOHFW site but i have try to keep it brief,hope its ll be useful specially for academic and administrative purposes.
This ppt contains all the information about Revised NationalTuberculosis Control programme (RNTCP) It is useful for students of the medical field learning Preventive and social medicine, Swasthavritta (Ayurved) and everyone who is interested in in knowing about it.
Developing a national strategy to bring pathogen genomics into practiceExternalEvents
http://www.fao.org/about/meetings/wgs-on-food-safety-management/en/
Developing a national strategy to bring pathogen genomics into practice. Presentation from the Technical Meeting on the impact of Whole Genome Sequencing (WGS) on food safety management and GMI-9, 23-25 May 2016, Rome, Italy.
Towards Strengthening Equity and Inclusiveness in NTD approaches : Who is lef...COUNTDOWN on NTDs
Ms Christine Makia presented this during an Organised Session titled - Beyond 2020 with Neglected Tropical Diseases: Leaving no one behind in the journey 2030; during the European Congress on Tropical Medicine and International Health on 18th September 2019 in Liverpool.
Participatory research methods to improve community engagement and programme ...COUNTDOWN on NTDs
This presentation was given by Dr Luret Lar, Research Manager COUNTDOWN Nigeria during the European Congress on Tropical Medicine and International Health on 17th September 2019. This was during an organised session titled 'Health systems and Neglected Tropical Diseases a policy and practice debate: Inclusion, integration, innovation and implementation.' It was chaired by Dr Rachael Thomson, COUNTDOWN Director and higlights were presented by Dr Akinola Oluwole and Professor Sally Theobald.
‘Health system strengthening through integrated case management of neglected ...COUNTDOWN on NTDs
11th European Congress on Tropical Medicine and International Health presentation during the COUNTDOWN organised session titled: Health systems and Neglected Tropical Diseases a policy and practice debate: Inclusion, integration, innovation and implementation. It was presented on 17th September 2019.
The Changing Landscape of Communicating Science: Tips & Tricks for dismantlin...COUNTDOWN on NTDs
GIFs used in Slides 14 & 15, created by Global Health Strategies for #UHC2017
This presentation was given by Pamela Bongkiyung at the Science Communications International Society of Neglected Tropical Diseases (ISNTD) festival held on Tuesday, 27th March 2018; at the Wellcome Trust in London.
Professor Russell Stothard's presentation given to The Royal College of Pathologists on 6th March 2018 during the National Infection Study Day event. Prof Stothard focused on schistosomiasis and urogenital schistosomiasis pathology
Highlighting Water, Hygiene & Sanitation at the International Society for Neg...COUNTDOWN on NTDs
Dr Lucas Cunningham gave this presentation at the ISNTD WASH event on 23rd Nov. 2017. He collaborated in a workshop with other partners from SCI and GSA to further elaborate on WASH and its implications for NTDs.
Prof. Sally Theobald and Ms Laura Dean from COUNTDOWN gave a keynote at the International Federation of Anti-Leprosy Associations meeting on Wednesday, 18th October 2017.
Addressing Neglected Parasitic Diseases: Moving towards the development agend...COUNTDOWN on NTDs
This presentation was given by Prof David Molyneux at the British Society of Parasitology Autumn Symposium, held at the Linnean Society in London on 28th September 2017.
http://bsp.uk.net/2016/10/04/bsp-autumn-symposium-2017/
Interrupting Schistosomiasis Transmission: Taking sensible steps in Snail Con...COUNTDOWN on NTDs
This presentation was given by Prof. Russell Stothard, at the ISNTD Bites event that took place on Tuesday, 19th July 2017. It highlights the work being done in Cameroon to control Schistosomiasis transmission by reducing the snail population.
Epidemiological Analysis Workshop By Dr Suzanne Campbell COUNTDOWN on NTDs
This workshop was held in Yaounde, Cameroon on 24th March 2017 as part of the 'Towards Elimination of Schistosomiasis: A Paradigm Shift' Conference organised by Prof. Louis Albert Tchuem Tchuente, Director of the Centre for Schistosomiasis and Parasitology.
This presentation by Prof. Russell Stothard, COUNTDOWN's Director was given at the WHO NTD Summit on Friday, 21st April 2017. This session on Schistosomiasis was organised by the Global Alliance for Schistosomiasis (GSA).
Schistosomiasis towards 2030: From Global Expectations to local realitiesCOUNTDOWN on NTDs
This presentation was given by Prof. Russell Stothard, in his capacity as COUNTDOWN Director to the Global Center for Infectious Diseases (GCID) Symposium in Korea and to the Korean Society for Parasitology in mid-Feb. 2017
ISNTD WASH Conference - 1st November 2016 by Suzy CampbellCOUNTDOWN on NTDs
Water, Sanitation and Hygiene have been identified as a key component in efforts to fight Neglected Tropical Diseases. The Water conference provided an opportunity to explore the solutions WASH offers.
On the 28-30 September 2015 NTD Programme Managers met at a World Health Organization meeting. Our colleague Benjamin Marfo provided the update from Ghana.
Gender, Equity, Disability and Neglected Tropical DiseasesCOUNTDOWN on NTDs
This presentation was given my Margaret Gyapong at the Coalition for Operational Research on Neglected Tropical Diseases (NTDs) (COR-NTD) meeting in 2015. She raises critical questions about the links between gender, equity, disability and NTDs.
Presentation given by Laura Dean at the Royal Society conference The disease elimination agenda: the role of science, policy and advocacy http://rstmh.org/events/disease-elimination-agenda-role-science-policy-and-advocacy
Neglected tropical disease and co-infection: Female Genital Schistosomiasis i...COUNTDOWN on NTDs
Margaret Gyapong spoke at the 9th European Congress on Tropical Medicine and International Health in Basel Spetember 2015. This is her presentation on female genital schistosomiasis.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
share - Lions, tigers, AI and health misinformation, oh my!.pptxTina Purnat
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
DISSERTATION on NEW DRUG DISCOVERY AND DEVELOPMENT STAGES OF DRUG DISCOVERYNEHA GUPTA
The process of drug discovery and development is a complex and multi-step endeavor aimed at bringing new pharmaceutical drugs to market. It begins with identifying and validating a biological target, such as a protein, gene, or RNA, that is associated with a disease. This step involves understanding the target's role in the disease and confirming that modulating it can have therapeutic effects. The next stage, hit identification, employs high-throughput screening (HTS) and other methods to find compounds that interact with the target. Computational techniques may also be used to identify potential hits from large compound libraries.
Following hit identification, the hits are optimized to improve their efficacy, selectivity, and pharmacokinetic properties, resulting in lead compounds. These leads undergo further refinement to enhance their potency, reduce toxicity, and improve drug-like characteristics, creating drug candidates suitable for preclinical testing. In the preclinical development phase, drug candidates are tested in vitro (in cell cultures) and in vivo (in animal models) to evaluate their safety, efficacy, pharmacokinetics, and pharmacodynamics. Toxicology studies are conducted to assess potential risks.
Before clinical trials can begin, an Investigational New Drug (IND) application must be submitted to regulatory authorities. This application includes data from preclinical studies and plans for clinical trials. Clinical development involves human trials in three phases: Phase I tests the drug's safety and dosage in a small group of healthy volunteers, Phase II assesses the drug's efficacy and side effects in a larger group of patients with the target disease, and Phase III confirms the drug's efficacy and monitors adverse reactions in a large population, often compared to existing treatments.
After successful clinical trials, a New Drug Application (NDA) is submitted to regulatory authorities for approval, including all data from preclinical and clinical studies, as well as proposed labeling and manufacturing information. Regulatory authorities then review the NDA to ensure the drug is safe, effective, and of high quality, potentially requiring additional studies. Finally, after a drug is approved and marketed, it undergoes post-marketing surveillance, which includes continuous monitoring for long-term safety and effectiveness, pharmacovigilance, and reporting of any adverse effects.
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
Antimicrobial stewardship to prevent antimicrobial resistanceGovindRankawat1
India is among the nations with the highest burden of bacterial infections.
India is one of the largest consumers of antibiotics worldwide.
India carries one of the largest burdens of drug‑resistant pathogens worldwide.
Highest burden of multidrug‑resistant tuberculosis,
Alarmingly high resistance among Gram‑negative and Gram‑positive bacteria even to newer antimicrobials such as carbapenems.
NDM‑1 ( New Delhi Metallo Beta lactamase 1, an enzyme which inactivates majority of Beta lactam antibiotics including carbapenems) was reported in 2008
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
A focus on NTDs in sub-Saharan Africa: Supporting scale-up of interventions
1. A focus on NTDs in sub-Saharan Africa:
Supporting scale-up of interventions
Russell Stothard & COUNTDOWN consortium
LSTM, UK
The COUNTDOWN project is a research programme funded by
The Research and Evidence Division (RED) of The Department for International Development (DFID).
8. • Introducing COUNTDOWN
• Changing NTD landscape: policies with practicalities
• Some examples with discussion points
• Outlook towards 2020 & 2030 targets
9. Changing NTD landscape: policies with practicalities
Community
Global
Regional
National
District
10. Flux of stakeholders & interests
Changing NTD landscape: policies with practicalities
https://www.infontd.org/
An A to Z of agencies
Alliance for Disability-Inclusive Development (ADID) ….WVI - World Vision International
Disease focused (pharmaceutical industry)
http://eliminateschisto.org/
www.who.int/topics/schistosomiasis/
11. Challenges in the provision of MDA, as NTDs are:
• Embedded in complex social/biological systems shaped by ecological/political contexts
• Control vertically focused, ‘outside’ the primary health care system in sub-Saharan Africa
• Promoting community ownership is central but is dynamic sometimes, often with
local complex power structures evolving as programmatic integration ensues
• Programmes need to adapt and reflect the realities of the communities they serve by
voicing opinions/needs of affected communities (NB: control to elimination settings)
Changing NTD landscape: policies with practicalities
12. Changing NTD landscape: policies with practicalities
5-points to consider:
1. A move from a single disease to addressing multiple
NTDs through a coordinated health systems approach
2. Strategic partnerships amongst multiple stakeholders
3. Robust and appropriate data for evidence-based action
4. A strong equity stance and focus upon addressing
poverty and achieving universal health coverage
5. Strong women’s leadership and roles in health
13. • Introducing COUNTDOWN
• Changing NTD landscape: policies with practicalities
• Some examples (schistosomiasis) with discussion points
• Outlook towards 2020 & 2030 targets
14. 1
2
3
Attack points in the lifecycleSome examples with discussion points
Schistosomiasis
250M+ with disease
Urogenital
• FGS/HIV
Intestinal
• Uganda
Access to PZQ
• ?affordable
16. Intestinal – Uganda: inter-sectoral engagement ACROSS the health system
Related-issues
Government
• UPE (coverage)
• UPE (erosion)
NGDO
• WVI
• Leeds University
17. Intestinal – Uganda: inter-sectoral engagement ACROSS the health system
Challenges in large lake settings
- natural or man-made
Infection starts soon after birth
- occupational risk
18. Access to PZQ: SEVERAL bottlenecks to be addressed for universal access
Drugs
donated/purchased/delivery
Deliverers
CDD or teachers or both
Maternal & child health
EPI
Recipients
Pre-SAC
SAC (in-school and out-of-school)
Adults - ?pregnant
Environment
Vectors/sanitation/modificationALB & PZQ drug distribution in Liberia 2012
20. Thank You
The COUNTDOWN project is a research programme funded by
The Research and Evidence Division (RED) of The Department for International Development (DFID).
Ghana
Cameroon
Liberia
Nigeria
UK
USA